Jennifer Augusti
Directeur Financier/CFO chez Xylocor Therapeutics, Inc.
Postes actifs de Jennifer Augusti
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Directeur des opérations | - | - |
| Directeur Financier/CFO | - | - |
Historique de carrière de Jennifer Augusti
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Chief Operating Officer | 1 |
| Director of Finance/CFO | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Xylocor Therapeutics, Inc.
Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Health Technology |
- Bourse
- Insiders
- Jennifer Augusti
- Expérience
